Archive

HIV Prevention Research & Development Investments, 2000–2016

HIV Prevention Research & Development Investments 2017

Investment priorities to fund innovation in a challenging global health landscape

HIV Prevention Research & Development Investments, 2000-2015

HIV Prevention Research & Development Investments, 2000-2015

Investment priorities to fund innovation in a challenging global health landscape

HIV Prevention Research & Development Funding Trends, 2000-2014

HIV Prevention Research & Development Funding Trends, 2000-2014

Investing in innovation in an evolving global health and development landscape

HIV Prevention Research & Development Investment in 2013

HIV Prevention Research & Development Investment in 2013

In a changing global development, economic, and human rights landscape

From Research to Reality

From Research to Reality

Investing in HIV Prevention Research in a Challenging Landscape

Investing to End the AIDS Epidemic

Investing to End the AIDS Epidemic

A New Era for HIV Prevention Research & Development

Capitalizing on Scientific Progress

Capitalizing on Scientific Progress

Investment in HIV Prevention R&D in 2010

Advancing the Science in a Time of Fiscal Constraint

Advancing the Science in a Time of Fiscal Constraint

Funding for HIV Prevention Technologies in 2009

Adapting to Realities

Adapting to Realities

Trends in Prevention Research funding 2000 to 2008

Sustaining the HIV Prevention Research Agenda

Funding for Research and Development of HIV Vaccines, Microbicides and Other New Prevention Options

Building a Comprehensive Response

Building a Comprehensive Response

Funding for HIV Vaccines, Microbicides and Other New Prevention Options, 2000-2006

Adding It All Up

Adding It All Up

Funding for HIV Vaccine and Microbicide Development, 2000-2005

Tracking Funding for Microbicide Research & Development

Tracking Funding for Microbicide Research & Development

Estimates of Annual Investments 2000 to 2005